25 XP   0   0   10

ProPhase Labs Inc
Buy, Hold or Sell?

Let's analyse ProPhase Labs Inc together

PenkeI guess you are interested in ProPhase Labs Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ProPhase Labs Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ProPhase Labs Inc

I send you an email if I find something interesting about ProPhase Labs Inc.

Quick analysis of ProPhase Labs Inc (30 sec.)










What can you expect buying and holding a share of ProPhase Labs Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.42
When do you have the money?
1 year
How often do you get paid?
45.0%

What is your share worth?

Current worth
$2.74
Expected worth in 1 year
$1.95
How sure are you?
57.5%

+ What do you gain per year?

Total Gains per Share
$-0.37
Return On Investment
-7.4%

For what price can you sell your share?

Current Price per Share
$4.95
Expected price per share
$4.335 - $7.48
How sure are you?
50%

1. Valuation of ProPhase Labs Inc (5 min.)




Live pricePrice per Share (EOD)

$4.95

Intrinsic Value Per Share

$-2.75 - $20.14

Total Value Per Share

$-0.02 - $22.88

2. Growth of ProPhase Labs Inc (5 min.)




Is ProPhase Labs Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$49.3m$66.5m-$10.2m-18.3%

How much money is ProPhase Labs Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.1m$4.6m-$8.8m-210.0%
Net Profit Margin-83.7%11.2%--

How much money comes from the company's main activities?

3. Financial Health of ProPhase Labs Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

What can you expect buying and holding a share of ProPhase Labs Inc? (5 min.)

Welcome investor! ProPhase Labs Inc's management wants to use your money to grow the business. In return you get a share of ProPhase Labs Inc.

What can you expect buying and holding a share of ProPhase Labs Inc?

First you should know what it really means to hold a share of ProPhase Labs Inc. And how you can make/lose money.

Speculation

The Price per Share of ProPhase Labs Inc is $4.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ProPhase Labs Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ProPhase Labs Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.74. Based on the TTM, the Book Value Change Per Share is $-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is $0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ProPhase Labs Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-9.8%-0.23-4.7%0.244.9%0.010.2%0.040.8%
Usd Book Value Change Per Share-0.39-7.9%-0.20-4.0%0.071.4%0.091.8%0.051.0%
Usd Dividend Per Share0.428.5%0.112.1%0.244.8%0.173.4%0.132.7%
Usd Total Gains Per Share0.030.6%-0.09-1.9%0.316.2%0.265.2%0.183.7%
Usd Price Per Share4.52-5.94-10.15-5.77-3.88-
Price to Earnings Ratio-2.33-11.70-13.00-6.51-7.00-
Price-to-Total Gains Ratio146.99--27.42-40.88-88.05-94.26-
Price to Book Ratio1.65-1.89-2.91-3.35-3.04-
Price-to-Total Gains Ratio146.99--27.42-40.88-88.05-94.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.95
Number of shares202
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.110.17
Usd Book Value Change Per Share-0.200.09
Usd Total Gains Per Share-0.090.26
Gains per Quarter (202 shares)-18.6152.39
Gains per Year (202 shares)-74.42209.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
185-159-8413674200
2170-319-158272147410
3255-478-232408221620
4340-638-306544294830
5425-797-3806803681040
6510-957-4548164421250
7596-1116-5289525151460
8681-1276-60210885891670
9766-1435-67612246621880
10851-1595-75013597362090

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%6.06.00.050.0%8.012.00.040.0%12.028.00.030.0%46.062.01.042.2%
Book Value Change Per Share0.04.00.00.0%5.07.00.041.7%6.014.00.030.0%13.027.00.032.5%46.062.01.042.2%
Dividend per Share1.00.03.025.0%9.00.03.075.0%14.00.06.070.0%18.00.022.045.0%18.00.091.016.5%
Total Gains per Share1.03.00.025.0%9.03.00.075.0%14.06.00.070.0%23.017.00.057.5%56.052.01.051.4%

Fundamentals of ProPhase Labs Inc

About ProPhase Labs Inc

ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also offers contract manufacturing services, such as consumer product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, it is involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Fundamental data was last updated by Penke on 2024-04-12 15:43:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ProPhase Labs Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ProPhase Labs Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -250.1% means that $-2.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ProPhase Labs Inc:

  • The MRQ is -250.1%. The company is making a huge loss. -2
  • The TTM is -83.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-250.1%TTM-83.7%-166.4%
TTM-83.7%YOY11.2%-94.9%
TTM-83.7%5Y-26.8%-56.9%
5Y-26.8%10Y115.7%-142.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-250.1%-6.7%-243.4%
TTM-83.7%-6.7%-77.0%
YOY11.2%0.3%+10.9%
5Y-26.8%-1.5%-25.3%
10Y115.7%-3.4%+119.1%
1.1.2. Return on Assets

Shows how efficient ProPhase Labs Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • -9.5% Return on Assets means that ProPhase Labs Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ProPhase Labs Inc:

  • The MRQ is -9.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-4.6%-4.9%
TTM-4.6%YOY4.6%-9.2%
TTM-4.6%5Y-1.3%-3.3%
5Y-1.3%10Y-1.4%+0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.5%-1.3%-8.2%
TTM-4.6%-1.3%-3.3%
YOY4.6%-0.9%+5.5%
5Y-1.3%-0.5%-0.8%
10Y-1.4%-0.9%-0.5%
1.1.3. Return on Equity

Shows how efficient ProPhase Labs Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • -17.7% Return on Equity means ProPhase Labs Inc generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ProPhase Labs Inc:

  • The MRQ is -17.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.7%TTM-7.9%-9.8%
TTM-7.9%YOY6.8%-14.8%
TTM-7.9%5Y-1.9%-6.1%
5Y-1.9%10Y-2.9%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.7%-0.5%-17.2%
TTM-7.9%--7.9%
YOY6.8%0.3%+6.5%
5Y-1.9%-1.4%-0.5%
10Y-2.9%-2.3%-0.6%

1.2. Operating Efficiency of ProPhase Labs Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ProPhase Labs Inc is operating .

  • Measures how much profit ProPhase Labs Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -324.4% means the company generated $-3.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ProPhase Labs Inc:

  • The MRQ is -324.4%. The company is operating very inefficient. -2
  • The TTM is -108.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-324.4%TTM-108.2%-216.3%
TTM-108.2%YOY13.8%-122.0%
TTM-108.2%5Y-30.8%-77.3%
5Y-30.8%10Y-32.1%+1.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-324.4%-6.2%-318.2%
TTM-108.2%0.5%-108.7%
YOY13.8%4.0%+9.8%
5Y-30.8%3.7%-34.5%
10Y-32.1%-1.3%-30.8%
1.2.2. Operating Ratio

Measures how efficient ProPhase Labs Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 4.24 means that the operating costs are $4.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ProPhase Labs Inc:

  • The MRQ is 4.244. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.081. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.244TTM2.081+2.163
TTM2.081YOY0.862+1.219
TTM2.0815Y1.327+0.754
5Y1.32710Y1.333-0.005
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2441.280+2.964
TTM2.0811.304+0.777
YOY0.8621.236-0.374
5Y1.3271.242+0.085
10Y1.3331.205+0.128

1.3. Liquidity of ProPhase Labs Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ProPhase Labs Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.28 means the company has $2.28 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ProPhase Labs Inc:

  • The MRQ is 2.281. The company is able to pay all its short-term debts. +1
  • The TTM is 3.088. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.281TTM3.088-0.807
TTM3.088YOY3.967-0.879
TTM3.0885Y6.216-3.128
5Y6.21610Y6.936-0.719
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2812.111+0.170
TTM3.0882.298+0.790
YOY3.9672.599+1.368
5Y6.2163.012+3.204
10Y6.9363.081+3.855
1.3.2. Quick Ratio

Measures if ProPhase Labs Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.14 means the company can pay off $2.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ProPhase Labs Inc:

  • The MRQ is 2.144. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.912. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.144TTM2.912-0.768
TTM2.912YOY3.887-0.975
TTM2.9125Y6.126-3.213
5Y6.12610Y7.723-1.597
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1441.204+0.940
TTM2.9121.319+1.593
YOY3.8871.602+2.285
5Y6.1261.943+4.183
10Y7.7232.203+5.520

1.4. Solvency of ProPhase Labs Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ProPhase Labs Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ProPhase Labs Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.46 means that ProPhase Labs Inc assets are financed with 46.3% credit (debt) and the remaining percentage (100% - 46.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ProPhase Labs Inc:

  • The MRQ is 0.463. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.392. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.463TTM0.392+0.071
TTM0.392YOY0.304+0.088
TTM0.3925Y0.297+0.096
5Y0.29710Y0.279+0.018
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4630.429+0.034
TTM0.3920.407-0.015
YOY0.3040.394-0.090
5Y0.2970.450-0.153
10Y0.2790.450-0.171
1.4.2. Debt to Equity Ratio

Measures if ProPhase Labs Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 86.2% means that company has $0.86 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ProPhase Labs Inc:

  • The MRQ is 0.862. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.654. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.862TTM0.654+0.208
TTM0.654YOY0.439+0.215
TTM0.6545Y0.515+0.139
5Y0.51510Y0.470+0.045
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8620.606+0.256
TTM0.6540.571+0.083
YOY0.4390.631-0.192
5Y0.5150.658-0.143
10Y0.4700.735-0.265

2. Market Valuation of ProPhase Labs Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings ProPhase Labs Inc generates.

  • Above 15 is considered overpriced but always compare ProPhase Labs Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -2.33 means the investor is paying $-2.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ProPhase Labs Inc:

  • The EOD is -2.552. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.330. Based on the earnings, the company is expensive. -2
  • The TTM is 11.704. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-2.552MRQ-2.330-0.222
MRQ-2.330TTM11.704-14.034
TTM11.704YOY12.995-1.291
TTM11.7045Y6.512+5.192
5Y6.51210Y7.002-0.490
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.552-0.235-2.317
MRQ-2.330-0.395-1.935
TTM11.704-0.284+11.988
YOY12.9950.002+12.993
5Y6.5124.834+1.678
10Y7.0025.200+1.802
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ProPhase Labs Inc:

  • The EOD is -14.662. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.389. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -214.956. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.662MRQ-13.389-1.274
MRQ-13.389TTM-214.956+201.568
TTM-214.956YOY-2.856-212.100
TTM-214.9565Y-48.180-166.776
5Y-48.18010Y-23.746-24.434
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-14.662-0.277-14.385
MRQ-13.389-0.441-12.948
TTM-214.956-1.389-213.567
YOY-2.856-2.030-0.826
5Y-48.180-1.446-46.734
10Y-23.746-1.971-21.775
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ProPhase Labs Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.65 means the investor is paying $1.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of ProPhase Labs Inc:

  • The EOD is 1.809. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.652. Based on the equity, the company is underpriced. +1
  • The TTM is 1.888. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.809MRQ1.652+0.157
MRQ1.652TTM1.888-0.237
TTM1.888YOY2.913-1.025
TTM1.8885Y3.352-1.463
5Y3.35210Y3.035+0.317
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.8091.897-0.088
MRQ1.6522.222-0.570
TTM1.8882.168-0.280
YOY2.9133.041-0.128
5Y3.3523.477-0.125
10Y3.0354.125-1.090
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of ProPhase Labs Inc.

3.1. Institutions holding ProPhase Labs Inc

Institutions are holding 9.556% of the shares of ProPhase Labs Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.37680.000160934775071.2473
2023-12-31Renaissance Technologies Corp1.36160.0017245710-38300-13.4854
2023-12-31HighTower Advisors, LLC0.95940.001317312400
2023-12-31Geode Capital Management, LLC0.76150.0001137409104108.1969
2023-12-31Perritt Capital Management Inc.0.4760.217285900-6400-6.9339
2023-12-31Goldman Sachs Group Inc0.4156074994-13169-14.9371
2023-12-31BlackRock Inc0.336706075415602.6354
2023-12-31BP WEALTH MANAGEMENT, LLC0.26410.00524766500
2023-12-31Northern Trust Corp0.25470459622253896.2176
2023-12-31Bank of New York Mellon Corp0.2357042531-20865-32.9122
2023-12-31State Street Corporation0.222604016300
2023-12-31Chapin Davis Inc0.22170.07624000000
2023-12-31Bank of America Corp0.2035036719-35-0.0952
2023-12-31Bridgeway Capital Management, LLC0.12530.002222606-9808-30.2585
2023-12-31T. Rowe Price Associates, Inc.0.095901730000
2023-12-31Commonwealth Equity Services Inc0.08880.000116027-2300-12.5498
2023-12-31Tower Research Capital LLC0.08320.000815010502650.3405
2023-12-31Morgan Stanley - Brokerage Accounts0.0287051802505.071
2023-12-31SIMPLEX TRADING, LLC0.0183032941013.1632
2023-09-30Citadel Advisors Llc0.0181032722737511.5888
Total 9.54820.30491722967-40748-2.4%

3.2. Funds holding ProPhase Labs Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.31340.000141746118930.4555
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.00520.000818139100
2024-02-29Fidelity Extended Market Index0.43170.000977909-377-0.4816
2024-02-29Belfund SICAV Belinvest Equity A USD Acc0.27710.23735000000
2023-12-31Perritt MicroCap Opportunities Investor0.22170.33134000000
2024-03-28iShares Micro-Cap ETF0.15870.02022863400
2023-09-30BlackRock Extended Mkt Composite0.14830.00082676600
2024-03-31BlackRock Extended Equity Market K0.12950.0012336080.0343
2024-02-29Fidelity Total Market Index0.11810.00012131300
2023-12-31Perritt Ultra MicroCap0.11080.81622000000
2024-02-29Fidelity Series Total Market Index0.09910.00011788400
2023-12-31T. Rowe Price U.S. Equities Tr0.09590.00081730000
2023-12-31Bridgeway Ultra-Small Company0.07920.07451428900
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06790.000212254-395791-96.9969
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06790.00021225400
2024-02-29Fidelity Nasdaq Composite Index0.06240.00031126200
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06190.00081117300
2023-12-31Northern Trust Extended Eq Market Idx0.06160.00091111800
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06160.00091111800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04970.00088973170.1898
Total 5.62171.48821014459-394250-38.9%

3.3. Insider Transactions

Insiders are holding 22.056% of the shares of ProPhase Labs Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-03-10Jason Michael BarrBUY7506.48

4. Summary

4.1. Key Performance Indicators

The key performance indicators of ProPhase Labs Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.390-0.197-49%0.069-663%0.091-529%0.051-866%
Book Value Per Share--2.7373.117-12%3.491-22%2.169+26%1.593+72%
Current Ratio--2.2813.088-26%3.967-42%6.216-63%6.936-67%
Debt To Asset Ratio--0.4630.392+18%0.304+52%0.297+56%0.279+66%
Debt To Equity Ratio--0.8620.654+32%0.439+96%0.515+67%0.470+83%
Dividend Per Share--0.4210.105+300%0.238+77%0.168+150%0.133+217%
Eps---0.485-0.233-52%0.241-301%0.010-4871%0.039-1339%
Free Cash Flow Per Share---0.084-0.201+138%0.325-126%-0.028-67%-0.033-60%
Free Cash Flow To Equity Per Share--0.078-0.121+256%-0.022+128%0.146-47%0.017+348%
Gross Profit Margin--1.0001.0000%1.0000%0.906+10%1.352-26%
Intrinsic Value_10Y_max--20.141--------
Intrinsic Value_10Y_min---2.754--------
Intrinsic Value_1Y_max--0.220--------
Intrinsic Value_1Y_min---0.159--------
Intrinsic Value_3Y_max--2.031--------
Intrinsic Value_3Y_min---0.581--------
Intrinsic Value_5Y_max--5.495--------
Intrinsic Value_5Y_min---1.115--------
Market Cap89322750.000+9%81563531.080107232445.270-24%194429937.500-58%106399124.304-23%71250222.040+14%
Net Profit Margin---2.501-0.837-67%0.112-2339%-0.268-89%1.157-316%
Operating Margin---3.244-1.082-67%0.138-2455%-0.308-90%-0.321-90%
Operating Ratio--4.2442.081+104%0.862+392%1.327+220%1.333+218%
Pb Ratio1.809+9%1.6521.888-13%2.913-43%3.352-51%3.035-46%
Pe Ratio-2.552-10%-2.33011.704-120%12.995-118%6.512-136%7.002-133%
Price Per Share4.950+9%4.5205.943-24%10.148-55%5.768-22%3.884+16%
Price To Free Cash Flow Ratio-14.662-10%-13.389-214.956+1506%-2.856-79%-48.180+260%-23.746+77%
Price To Total Gains Ratio160.968+9%146.985-27.421+119%40.876+260%88.046+67%94.257+56%
Quick Ratio--2.1442.912-26%3.887-45%6.126-65%7.723-72%
Return On Assets---0.095-0.046-52%0.046-308%-0.013-86%-0.014-86%
Return On Equity---0.177-0.079-55%0.068-360%-0.019-89%-0.029-84%
Total Gains Per Share--0.031-0.092+400%0.307-90%0.259-88%0.184-83%
Usd Book Value--49383000.00056252250.000-12%66538750.000-26%39864000.000+24%29119650.000+70%
Usd Book Value Change Per Share---0.390-0.197-49%0.069-663%0.091-529%0.051-866%
Usd Book Value Per Share--2.7373.117-12%3.491-22%2.169+26%1.593+72%
Usd Dividend Per Share--0.4210.105+300%0.238+77%0.168+150%0.133+217%
Usd Eps---0.485-0.233-52%0.241-301%0.010-4871%0.039-1339%
Usd Free Cash Flow---1523000.000-3625750.000+138%6158000.000-125%-442000.000-71%-574675.000-62%
Usd Free Cash Flow Per Share---0.084-0.201+138%0.325-126%-0.028-67%-0.033-60%
Usd Free Cash Flow To Equity Per Share--0.078-0.121+256%-0.022+128%0.146-47%0.017+348%
Usd Market Cap89322750.000+9%81563531.080107232445.270-24%194429937.500-58%106399124.304-23%71250222.040+14%
Usd Price Per Share4.950+9%4.5205.943-24%10.148-55%5.768-22%3.884+16%
Usd Profit---8751000.000-4195500.000-52%4616000.000-290%134200.000-6621%711825.000-1329%
Usd Revenue--3499000.00011096000.000-68%30661500.000-89%13523100.000-74%8928550.000-61%
Usd Total Gains Per Share--0.031-0.092+400%0.307-90%0.259-88%0.184-83%
 EOD+6 -2MRQTTM+13 -22YOY+9 -265Y+10 -2610Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of ProPhase Labs Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.552
Price to Book Ratio (EOD)Between0-11.809
Net Profit Margin (MRQ)Greater than0-2.501
Operating Margin (MRQ)Greater than0-3.244
Quick Ratio (MRQ)Greater than12.144
Current Ratio (MRQ)Greater than12.281
Debt to Asset Ratio (MRQ)Less than10.463
Debt to Equity Ratio (MRQ)Less than10.862
Return on Equity (MRQ)Greater than0.15-0.177
Return on Assets (MRQ)Greater than0.05-0.095
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of ProPhase Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.029
Ma 20Greater thanMa 506.125
Ma 50Greater thanMa 1005.507
Ma 100Greater thanMa 2005.186
OpenGreater thanClose5.060
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Retained Earnings  11,75355012,303-3,4408,863-5,1413,722-8,751-5,029
Gross Profit  11,283-76310,520-4,0726,448-4,1212,327-5,383-3,056



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets91,927
Total Liabilities42,544
Total Stockholder Equity49,383
 As reported
Total Liabilities 42,544
Total Stockholder Equity+ 49,383
Total Assets = 91,927

Assets

Total Assets91,927
Total Current Assets47,585
Long-term Assets44,342
Total Current Assets
Cash And Cash Equivalents 2,149
Short-term Investments 3,127
Net Receivables 36,313
Inventory 3,841
Other Current Assets 2,155
Total Current Assets  (as reported)47,585
Total Current Assets  (calculated)47,585
+/-0
Long-term Assets
Property Plant Equipment 17,470
Goodwill 5,231
Intangible Assets 12,333
Long-term Assets Other 1,995
Long-term Assets  (as reported)44,342
Long-term Assets  (calculated)37,029
+/- 7,313

Liabilities & Shareholders' Equity

Total Current Liabilities20,857
Long-term Liabilities21,687
Total Stockholder Equity49,383
Total Current Liabilities
Short-term Debt 2,793
Accounts payable 9,383
Other Current Liabilities 6,299
Total Current Liabilities  (as reported)20,857
Total Current Liabilities  (calculated)18,475
+/- 2,382
Long-term Liabilities
Long term Debt 10,258
Capital Lease Obligations 11,122
Long-term Liabilities  (as reported)21,687
Long-term Liabilities  (calculated)21,380
+/- 307
Total Stockholder Equity
Common Stock18
Retained Earnings -5,029
Accumulated Other Comprehensive Income -300
Other Stockholders Equity 54,694
Total Stockholder Equity (as reported)49,383
Total Stockholder Equity (calculated)49,383
+/-0
Other
Capital Stock18
Cash and Short Term Investments 5,276
Common Stock Shares Outstanding 18,045
Current Deferred Revenue2,382
Liabilities and Stockholders Equity 91,927
Net Debt 19,231
Net Invested Capital 59,641
Net Working Capital 26,728
Property Plant and Equipment Gross 29,004
Short Long Term Debt Total 21,380



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-31
> Total Assets 
6,950
24,200
18,400
30,400
49,800
47,100
46,600
49,900
48,600
40,600
31,400
30,800
33,300
26,767
23,633
25,248
26,056
23,815
22,960
23,730
24,756
22,369
24,744
25,242
24,935
22,730
21,870
22,999
26,270
26,270
22,406
22,842
31,530
30,488
26,398
31,543
35,976
31,911
28,707
31,341
34,845
31,998
29,255
30,936
33,314
28,806
25,557
26,571
24,369
21,635
16,495
18,188
19,817
22,179
19,849
22,357
21,695
19,889
17,746
20,318
19,079
17,922
15,175
16,534
16,661
16,139
15,067
16,667
17,420
17,267
19,760
17,920
16,057
14,994
12,039
13,852
14,829
13,325
11,544
12,787
12,802
57,543
50,099
39,082
34,161
34,220
22,123
20,575
20,737
16,572
15,799
15,601
12,274
11,868
12,375
23,033
31,405
85,444
76,323
72,630
89,295
99,665
97,947
97,877
87,648
95,374
91,058
91,710
91,927
91,92791,71091,05895,37487,64897,87797,94799,66589,29572,63076,32385,44431,40523,03312,37511,86812,27415,60115,79916,57220,73720,57522,12334,22034,16139,08250,09957,54312,80212,78711,54413,32514,82913,85212,03914,99416,05717,92019,76017,26717,42016,66715,06716,13916,66116,53415,17517,92219,07920,31817,74619,88921,69522,35719,84922,17919,81718,18816,49521,63524,36926,57125,55728,80633,31430,93629,25531,99834,84531,34128,70731,91135,97631,54326,39830,48831,53022,84222,40626,27026,27022,99921,87022,73024,93525,24224,74422,36924,75623,73022,96023,81526,05625,24823,63326,76733,30030,80031,40040,60048,60049,90046,60047,10049,80030,40018,40024,2006,950
   > Total Current Assets 
6,610
22,300
16,400
28,800
49,200
46,500
45,800
49,200
47,000
39,000
29,700
28,800
30,700
24,295
20,734
22,225
23,470
20,892
20,066
20,972
22,181
19,844
22,094
22,554
22,476
20,327
19,525
20,490
23,740
23,740
20,005
20,556
24,961
24,186
20,297
25,660
30,248
26,337
23,356
26,208
29,793
27,069
24,477
26,296
28,835
24,540
21,486
22,632
20,666
18,019
13,641
15,444
17,233
16,055
13,739
16,327
15,756
14,037
11,797
14,388
13,195
12,048
9,180
10,505
10,719
10,251
8,995
10,579
11,279
11,173
13,674
15,436
13,458
12,436
9,179
10,835
11,879
10,272
8,480
9,735
9,627
49,662
42,224
33,733
28,919
31,573
19,547
18,096
18,238
14,126
13,429
13,219
9,945
9,505
10,242
17,910
15,887
67,247
58,492
43,903
61,317
72,555
70,275
70,326
60,833
61,279
54,966
49,794
47,585
47,58549,79454,96661,27960,83370,32670,27572,55561,31743,90358,49267,24715,88717,91010,2429,5059,94513,21913,42914,12618,23818,09619,54731,57328,91933,73342,22449,6629,6279,7358,48010,27211,87910,8359,17912,43613,45815,43613,67411,17311,27910,5798,99510,25110,71910,5059,18012,04813,19514,38811,79714,03715,75616,32713,73916,05517,23315,44413,64118,01920,66622,63221,48624,54028,83526,29624,47727,06929,79326,20823,35626,33730,24825,66020,29724,18624,96120,55620,00523,74023,74020,49019,52520,32722,47622,55422,09419,84422,18120,97220,06620,89223,47022,22520,73424,29530,70028,80029,70039,00047,00049,20045,80046,50049,20028,80016,40022,3006,610
       Cash And Cash Equivalents 
2,460
9,000
6,600
7,700
25,500
32,300
28,900
26,700
28,300
23,700
14,700
13,400
14,000
12,106
8,214
10,107
11,366
9,707
8,695
7,585
9,741
10,751
12,839
11,292
12,897
13,315
12,385
10,647
11,392
11,392
13,736
11,703
14,366
16,481
13,979
12,173
16,885
18,190
16,060
13,597
17,757
19,176
15,843
12,484
16,085
16,265
14,375
10,880
11,957
12,244
9,217
8,945
12,801
12,352
11,163
8,705
8,232
9,586
8,743
4,616
5,541
6,268
4,610
1,815
572
4,536
4,058
751
1,638
5,519
7,350
4,953
2,926
5,021
3,761
1,336
1,664
2,457
1,149
375
441
42,800
37,280
3,897
3,173
3,387
3,665
2,269
1,554
2,450
1,049
968
434
697
2,537
10,860
6,816
32,727
17,677
8,533
8,408
25,807
23,959
22,799
9,109
9,613
3,824
702
2,149
2,1497023,8249,6139,10922,79923,95925,8078,4088,53317,67732,7276,81610,8602,5376974349681,0492,4501,5542,2693,6653,3873,1733,89737,28042,8004413751,1492,4571,6641,3363,7615,0212,9264,9537,3505,5191,6387514,0584,5365721,8154,6106,2685,5414,6168,7439,5868,2328,70511,16312,35212,8018,9459,21712,24411,95710,88014,37516,26516,08512,48415,84319,17617,75713,59716,06018,19016,88512,17313,97916,48114,36611,70313,73611,39211,39210,64712,38513,31512,89711,29212,83910,7519,7417,5858,6959,70711,36610,1078,21412,10614,00013,40014,70023,70028,30026,70028,90032,30025,5007,7006,6009,0002,460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,641
18,765
18,327
6,776
6,866
6,687
4,229
4,685
3,760
926
840
3,339
1,403
1,639
3,531
18,574
14,328
8,855
3,543
3,539
3,678
8,328
5,946
5,280
2,565
3,127
3,1272,5655,2805,9468,3283,6783,5393,5438,85514,32818,5743,5311,6391,4033,3398409263,7604,6854,2296,6876,8666,77618,32718,76523,6410000000000000000000000000000050000000000000000000000000000000000000000000000000000000
       Net Receivables 
2,460
12,300
1,400
7,500
10,900
1,100
400
8,200
7,600
2,600
1,000
3,400
6,600
2,233
1,860
3,832
4,063
2,185
1,360
4,917
4,425
2,056
1,784
4,243
4,188
2,022
1,800
4,600
7,862
7,862
1,362
3,968
6,376
3,270
1,623
8,530
7,880
2,685
1,181
6,701
6,557
2,746
1,717
6,959
6,673
3,379
1,613
5,499
4,524
1,796
153
2,487
2,086
1,357
855
4,791
4,821
2,506
1,162
4,419
3,219
2,542
938
4,172
5,409
3,080
1,128
4,445
5,319
2,856
2,343
4,051
5,836
3,468
1,245
2,766
4,000
2,688
1,801
3,833
5,770
3,410
1,835
3,613
4,947
7,287
6,363
5,891
7,798
5,618
5,566
6,311
6,822
6,025
1,930
2,999
3,155
14,344
6,644
10,680
37,708
36,694
36,670
37,832
37,054
37,836
38,572
38,642
36,313
36,31338,64238,57237,83637,05437,83236,67036,69437,70810,6806,64414,3443,1552,9991,9306,0256,8226,3115,5665,6187,7985,8916,3637,2874,9473,6131,8353,4105,7703,8331,8012,6884,0002,7661,2453,4685,8364,0512,3432,8565,3194,4451,1283,0805,4094,1729382,5423,2194,4191,1622,5064,8214,7918551,3572,0862,4871531,7964,5245,4991,6133,3796,6736,9591,7172,7466,5576,7011,1812,6857,8808,5301,6233,2706,3763,9681,3627,8627,8624,6001,8002,0224,1884,2431,7842,0564,4254,9171,3602,1854,0633,8321,8602,2336,6003,4001,0002,6007,6008,2004001,10010,9007,5001,40012,3002,460
       Inventory 
300
800
7,400
9,900
7,700
7,300
8,500
7,900
6,500
6,700
7,100
7,100
6,200
6,018
6,671
7,026
6,918
7,633
7,337
7,006
6,508
5,976
6,620
6,346
4,527
4,409
4,546
4,526
3,753
3,753
4,295
4,270
3,455
3,417
3,761
3,998
3,900
4,228
4,797
5,042
4,262
4,164
5,877
5,803
4,812
4,312
4,621
5,074
3,001
3,246
3,100
3,180
1,405
1,134
1,153
2,368
1,682
1,345
1,594
3,518
2,688
2,611
3,141
3,414
2,051
2,147
3,289
3,273
2,521
2,212
3,248
4,180
3,292
3,277
3,705
4,891
4,331
4,072
4,349
4,198
2,736
2,155
1,966
1,992
1,531
2,010
2,386
2,717
1,903
1,611
2,026
1,886
1,459
1,703
2,047
2,138
3,039
16,026
15,169
8,510
4,600
4,680
4,509
4,912
3,976
4,311
3,623
5,054
3,841
3,8415,0543,6234,3113,9764,9124,5094,6804,6008,51015,16916,0263,0392,1382,0471,7031,4591,8862,0261,6111,9032,7172,3862,0101,5311,9921,9662,1552,7364,1984,3494,0724,3314,8913,7053,2773,2924,1803,2482,2122,5213,2733,2892,1472,0513,4143,1412,6112,6883,5181,5941,3451,6822,3681,1531,1341,4053,1803,1003,2463,0015,0744,6214,3124,8125,8035,8774,1644,2625,0424,7974,2283,9003,9983,7613,4173,4554,2704,2953,7533,7534,5264,5464,4094,5276,3466,6205,9766,5087,0067,3377,6336,9187,0266,6716,0186,2007,1007,1006,7006,5007,9008,5007,3007,7009,9007,400800300
       Other Current Assets 
1,390
200
1,000
3,700
5,100
5,800
8,000
6,400
4,600
6,000
6,900
4,900
3,900
3,938
3,989
1,260
1,123
1,367
2,674
1,464
1,507
1,060
851
672
374
581
794
717
734
734
612
615
764
1,018
935
960
1,583
1,233
1,318
868
1,217
984
1,039
1,051
1,266
584
877
1,179
1,185
733
199
199
138
138
138
138
1,021
600
298
1,835
1,747
627
491
1,104
8,668
8,104
520
2,110
1,801
586
733
2,252
10,166
670
468
1,842
7,548
6,200
1,181
1,329
680
598
849
568
481
562
357
353
296
12,515
103
294
304
240
213
15,772
1,238
619
428
1,602
1,496
1,831
1,598
1,105
2,366
3,573
3,667
2,831
2,155
2,1552,8313,6673,5732,3661,1051,5981,8311,4961,6024286191,23815,77221324030429410312,5152963533575624815688495986801,3291,1816,2007,5481,84246867010,1662,2527335861,8012,1105208,1048,6681,1044916271,7471,8352986001,0211381381381381991997331,1851,1798775841,2661,0511,0399841,2178681,3181,2331,5839609351,0187646156127347347177945813746728511,0601,5071,4642,6741,3671,1231,2603,9893,9383,9004,9006,9006,0004,6006,4008,0005,8005,1003,7001,0002001,390
   > Long-term Assets 
340
1,900
2,000
1,600
600
600
800
700
1,600
1,600
1,700
2,000
2,600
2,472
2,899
3,023
2,586
2,924
2,894
2,758
2,574
2,526
2,649
2,688
2,459
2,403
2,344
2,509
2,529
2,529
2,401
2,286
6,568
6,301
6,101
5,883
5,727
5,574
5,351
5,133
5,052
4,929
4,778
4,639
4,478
4,266
4,071
3,939
3,702
3,616
2,854
2,744
2,584
6,124
6,110
6,030
5,939
5,852
5,949
5,930
5,884
5,874
5,995
6,029
5,942
5,888
6,072
6,088
6,141
6,094
6,086
2,484
2,599
2,558
2,860
3,017
2,950
3,053
3,064
3,052
3,175
7,881
7,875
5,349
5,242
2,647
2,576
2,479
2,499
2,446
2,370
2,382
2,329
2,363
2,133
5,123
15,518
18,197
17,831
28,727
27,978
27,110
27,672
27,551
26,815
34,095
36,092
41,916
44,342
44,34241,91636,09234,09526,81527,55127,67227,11027,97828,72717,83118,19715,5185,1232,1332,3632,3292,3822,3702,4462,4992,4792,5762,6475,2425,3497,8757,8813,1753,0523,0643,0532,9503,0172,8602,5582,5992,4846,0866,0946,1416,0886,0725,8885,9426,0295,9955,8745,8845,9305,9495,8525,9396,0306,1106,1242,5842,7442,8543,6163,7023,9394,0714,2664,4784,6394,7784,9295,0525,1335,3515,5745,7275,8836,1016,3016,5682,2862,4012,5292,5292,5092,3442,4032,4592,6882,6492,5262,5742,7582,8942,9242,5863,0232,8992,4722,6002,0001,7001,6001,6007008006006001,6002,0001,900340
       Property Plant Equipment 
70
100
100
200
200
200
300
300
1,000
1,000
1,100
1,400
1,900
1,967
2,113
2,187
2,140
2,332
2,339
2,255
2,201
2,171
2,296
2,332
2,337
2,291
2,233
2,398
2,418
2,418
2,255
2,192
6,474
6,162
5,894
5,646
5,586
5,423
5,230
5,011
4,838
4,798
4,645
4,517
4,355
4,168
4,035
3,904
3,667
3,581
2,818
2,710
2,572
2,535
2,521
2,453
2,362
2,275
2,372
2,353
2,307
2,297
2,418
2,452
2,365
2,311
2,495
2,511
2,564
2,517
2,509
2,484
2,599
2,558
2,860
3,017
2,950
3,053
3,064
3,052
3,175
2,881
2,875
2,849
2,742
2,647
2,576
2,479
2,499
2,446
2,370
2,382
2,329
2,363
2,133
2,123
8,309
11,724
11,478
10,938
10,349
10,759
10,486
10,211
11,347
12,865
13,619
17,843
17,470
17,47017,84313,61912,86511,34710,21110,48610,75910,34910,93811,47811,7248,3092,1232,1332,3632,3292,3822,3702,4462,4992,4792,5762,6472,7422,8492,8752,8813,1753,0523,0643,0532,9503,0172,8602,5582,5992,4842,5092,5172,5642,5112,4952,3112,3652,4522,4182,2972,3072,3532,3722,2752,3622,4532,5212,5352,5722,7102,8183,5813,6673,9044,0354,1684,3554,5174,6454,7984,8385,0115,2305,4235,5865,6465,8946,1626,4742,1922,2552,4182,4182,3982,2332,2912,3372,3322,2962,1712,2012,2552,3392,3322,1402,1872,1131,9671,9001,4001,1001,0001,00030030020020020010010070
       Goodwill 
270
400
400
400
400
400
300
300
300
300
200
200
200
176
154
501
439
529
436
435
327
327
327
327
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
0
0
0
0
0
0
0
0
0
0
0
0
0
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
901
901
901
1,385
5,709
5,709
5,709
5,709
5,709
5,231
5,231
5,231
5,231
5,2315,2315,2315,2315,7095,7095,7095,7095,7091,38590190190100000000000000000000000003,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,577000000000000031313131313131313131313131313131327327327327435436529439501154176200200200300300300300400400400400400270
       Intangible Assets 
270
400
400
400
400
400
300
300
300
300
200
200
200
176
154
501
439
529
66
44
22
327
327
327
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
0
0
0
0
0
0
0
0
0
0
0
0
0
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,234
1,125
1,017
11,562
10,852
10,143
9,434
8,889
8,475
14,524
13,769
13,015
12,333
12,33313,01513,76914,5248,4758,8899,43410,14310,85211,5621,0171,1251,23400000000000000000000000003,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,577000000000000031313131313131313131313131313131327327327224466529439501154176200200200300300300300400400400400400270
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
505
786
836
446
591
555
502
373
354
353
356
122
111
111
111
112
164
146
94
95
140
207
236
142
151
121
122
214
131
133
122
123
98
36
35
35
35
36
34
12
3,589
3,589
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
3,577
0
0
0
0
0
0
0
0
0
0
5,000
5,000
2,500
2,500
0
0
0
0
2,446
0
0
0
0
2,133
3,000
8,166
4,447
4,435
4,842
1,068
499
2,043
2,742
1,284
0
3,473
0
0
003,47301,2842,7422,0434991,0684,8424,4354,4478,1663,0002,13300002,44600002,5002,5005,0005,00000000000003,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5893,589123436353535369812312213313121412212115114223620714095941461641121111111111223563533543735025555914468367865050000000000000
> Total Liabilities 
1,410
12,600
5,700
7,100
8,100
4,000
1,900
3,600
4,000
3,400
1,800
2,800
7,100
4,475
2,993
4,090
4,848
2,997
2,893
3,463
3,556
2,870
3,017
4,016
6,512
5,253
5,432
6,428
5,483
5,483
3,241
3,759
9,573
8,641
6,345
8,494
10,602
7,903
5,817
7,372
9,252
8,332
9,105
9,302
10,016
7,124
6,749
6,839
6,595
6,060
5,528
5,911
5,758
6,563
6,361
7,861
8,235
7,358
5,788
7,574
7,853
7,296
6,403
6,643
5,210
4,164
4,771
5,041
4,824
4,464
6,152
7,382
5,341
5,624
3,677
3,815
6,000
5,831
5,177
6,253
6,840
6,873
3,473
2,432
1,072
1,100
1,595
876
4,233
870
1,147
1,202
1,043
1,237
1,481
12,272
20,849
32,779
28,590
24,366
30,667
33,220
29,789
29,956
24,017
35,433
31,801
35,282
42,544
42,54435,28231,80135,43324,01729,95629,78933,22030,66724,36628,59032,77920,84912,2721,4811,2371,0431,2021,1478704,2338761,5951,1001,0722,4323,4736,8736,8406,2535,1775,8316,0003,8153,6775,6245,3417,3826,1524,4644,8245,0414,7714,1645,2106,6436,4037,2967,8537,5745,7887,3588,2357,8616,3616,5635,7585,9115,5286,0606,5956,8396,7497,12410,0169,3029,1058,3329,2527,3725,8177,90310,6028,4946,3458,6419,5733,7593,2415,4835,4836,4285,4325,2536,5124,0163,0172,8703,5563,4632,8932,9974,8484,0902,9934,4757,1002,8001,8003,4004,0003,6001,9004,0008,1007,1005,70012,6001,410
   > Total Current Liabilities 
1,410
11,800
4,800
6,300
8,100
4,000
1,900
3,600
4,000
3,400
1,800
2,800
7,100
4,475
2,993
4,090
4,848
2,997
2,893
3,463
3,556
2,870
3,017
4,016
6,512
5,253
5,432
6,428
5,483
5,483
3,241
3,759
7,109
6,284
5,095
7,351
9,566
7,903
5,817
7,372
9,252
8,332
9,105
9,302
10,016
7,124
6,749
6,839
6,595
6,060
5,528
5,911
5,758
6,563
6,361
7,861
8,235
7,358
5,788
7,574
7,853
7,296
6,403
6,643
4,910
3,864
4,471
4,741
4,624
4,264
5,952
7,182
5,241
5,524
3,577
3,715
4,534
4,359
5,177
6,253
6,840
6,873
3,473
2,432
1,072
1,100
1,595
876
4,233
870
956
1,073
933
1,125
1,395
2,145
6,294
18,289
14,174
9,932
15,524
19,770
16,722
16,693
16,075
18,467
14,786
16,406
20,857
20,85716,40614,78618,46716,07516,69316,72219,77015,5249,93214,17418,2896,2942,1451,3951,1259331,0739568704,2338761,5951,1001,0722,4323,4736,8736,8406,2535,1774,3594,5343,7153,5775,5245,2417,1825,9524,2644,6244,7414,4713,8644,9106,6436,4037,2967,8537,5745,7887,3588,2357,8616,3616,5635,7585,9115,5286,0606,5956,8396,7497,12410,0169,3029,1058,3329,2527,3725,8177,9039,5667,3515,0956,2847,1093,7593,2415,4835,4836,4285,4325,2536,5124,0163,0172,8703,5563,4632,8932,9974,8484,0902,9934,4757,1002,8001,8003,4004,0003,6001,9004,0008,1006,3004,80011,8001,410
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
429
429
429
429
429
1,321
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,466
0
1,478
1,484
1,490
400
0
0
0
0
1,097
0
3,591
0
0
0
0
0
0
1,403
329
484
635
676
663
654
628
301
301
298
1,478
2,787
2,793
2,7932,7871,4782983013016286546636766354843291,4030000003,59101,09700004001,4901,4841,47801,466000000000000000000000000000000000000001,32142942942942942900000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,466
0
0
0
1,490
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001,4900001,4660000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
130
900
1,300
1,400
1,100
300
700
500
800
100
300
200
400
313
460
490
764
425
316
482
912
601
913
847
395
440
683
422
524
524
536
426
978
971
546
698
772
687
525
702
886
662
1,421
736
538
477
505
627
694
291
171
346
482
306
232
761
489
314
131
726
885
822
526
537
1,296
678
1,027
1,298
1,011
992
1,399
2,108
667
1,231
646
919
990
1,562
1,372
1,968
2,156
559
916
503
562
544
445
380
437
258
442
374
432
695
844
836
3,771
7,780
7,114
2,394
7,026
8,204
4,445
1,545
5,905
4,866
4,786
5,467
9,383
9,3835,4674,7864,8665,9051,5454,4458,2047,0262,3947,1147,7803,7718368446954323744422584373804455445625039165592,1561,9681,3721,5629909196461,2316672,1081,3999921,0111,2981,0276781,2965375268228857261313144897612323064823461712916946275054775387361,4216628867025256877726985469719784265365245244226834403958479136019124823164257644904603134002003001008005007003001,1001,4001,300900130
       Other Current Liabilities 
1,280
10,900
3,500
4,900
7,000
3,700
1,200
3,100
3,200
3,300
1,500
2,600
6,700
4,162
2,534
3,600
4,084
2,572
2,577
2,981
2,644
2,268
2,104
3,170
6,117
4,813
4,749
6,006
4,959
4,959
2,705
3,333
1,986
2,777
2,482
2,807
2,204
2,227
5,292
6,670
8,366
7,670
7,685
8,565
9,479
6,646
6,243
6,212
5,901
5,769
5,358
5,565
5,276
6,257
6,129
7,100
7,746
7,044
5,657
6,848
6,968
6,474
5,877
6,106
3,614
3,186
3,444
3,443
3,613
3,272
4,553
5,074
4,574
4,293
2,931
2,796
3,544
2,797
440
503
389
6,314
2,557
1,929
510
465
1
494
-1
493
403
581
397
337
416
1,127
2,025
9,896
6,313
5,345
5,801
8,666
9,219
11,889
7,370
10,462
5,162
5,705
6,299
6,2995,7055,16210,4627,37011,8899,2198,6665,8015,3456,3139,8962,0251,127416337397581403493-149414655101,9292,5576,3143895034402,7973,5442,7962,9314,2934,5745,0744,5533,2723,6133,4433,4443,1863,6146,1065,8776,4746,9686,8485,6577,0447,7467,1006,1296,2575,2765,5655,3585,7695,9016,2126,2436,6469,4798,5657,6857,6708,3666,6705,2922,2272,2042,8072,4822,7771,9863,3332,7054,9594,9596,0064,7494,8136,1173,1702,1042,2682,6442,9812,5772,5724,0843,6002,5344,1626,7002,6001,5003,3003,2003,1001,2003,7007,0004,9003,50010,9001,280
   > Long-term Liabilities 
130
800
900
800
1,100
300
700
500
800
100
300
200
400
313
460
490
764
425
316
482
912
601
913
847
395
440
683
422
0
524
536
426
2,464
2,357
1,250
1,143
1,036
2,008
525
702
886
662
1,421
736
538
477
505
627
694
291
171
346
482
306
232
761
489
314
131
726
885
822
526
537
300
300
300
300
200
200
200
200
100
100
100
100
1,466
1,472
2,850
3,452
3,646
559
916
503
562
635
497
382
643
377
191
129
110
112
86
10,127
14,555
14,490
14,416
14,434
15,143
13,450
13,067
13,263
7,942
16,966
17,015
18,876
21,687
21,68718,87617,01516,9667,94213,26313,06713,45015,14314,43414,41614,49014,55510,127861121101291913776433824976355625039165593,6463,4522,8501,4721,4661001001001002002002002003003003003005375268228857261313144897612323064823461712916946275054775387361,4216628867025252,0081,0361,1431,2502,3572,46442653652404226834403958479136019124823164257644904603134002003001008005007003001,100800900800130
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
1,466
1,472
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,990
9,991
9,993
9,994
0
0
8,015
7,998
7,999
0
9,624
9,646
0
0
009,6469,62407,9997,9988,015009,9949,9939,9919,990000000000000000001,4721,46610010000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
300
300
300
200
200
200
200
100
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191
129
110
112
86
137
162
149
121
106
905
1,301
983
927
1,283
0
3,111
0
0
003,11101,2839279831,30190510612114916213786112110129191000000000000001001001001002002002002003003003003000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
443
0
0
0
0
0
0
0
000000044300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
5,540
11,600
12,700
23,300
41,700
43,100
44,700
46,300
44,600
37,200
29,600
28,000
26,200
22,292
20,640
20,819
20,971
20,581
19,901
20,215
21,200
19,500
21,726
21,226
18,423
17,476
16,437
16,571
20,787
20,787
19,107
19,024
21,902
21,788
19,997
22,996
25,320
23,951
22,830
23,909
25,529
23,601
20,082
21,573
23,244
21,683
18,808
19,733
17,774
15,575
10,967
12,277
14,059
15,616
13,488
14,496
13,460
12,531
11,958
12,744
11,226
10,626
8,772
9,891
11,451
11,975
10,296
11,626
12,596
12,803
13,608
10,538
10,716
9,370
8,362
10,037
8,829
7,494
6,367
6,534
5,962
50,670
46,626
36,650
33,089
33,120
20,528
19,699
16,504
15,702
14,652
14,399
11,231
10,631
10,894
10,761
10,556
52,665
47,733
48,264
58,628
66,445
68,158
67,921
63,631
59,941
59,257
56,428
49,383
49,38356,42859,25759,94163,63167,92168,15866,44558,62848,26447,73352,66510,55610,76110,89410,63111,23114,39914,65215,70216,50419,69920,52833,12033,08936,65046,62650,6705,9626,5346,3677,4948,82910,0378,3629,37010,71610,53813,60812,80312,59611,62610,29611,97511,4519,8918,77210,62611,22612,74411,95812,53113,46014,49613,48815,61614,05912,27710,96715,57517,77419,73318,80821,68323,24421,57320,08223,60125,52923,90922,83023,95125,32022,99619,99721,78821,90219,02419,10720,78720,78716,57116,43717,47618,42321,22621,72619,50021,20020,21519,90120,58120,97120,81920,64022,29226,20028,00029,60037,20044,60046,30044,70043,10041,70023,30012,70011,6005,540
   Common Stock
10
0
0
0
0
0
0
0
0
0
0
0
7,400
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
10
10
11
11
11
11
11
11
12
12
13
13
13
13
13
13
13
13
13
13
13
13
14
14
14
14
14
14
14
14
14
14
14
14
14
16
16
16
16
16
16
17
16
17
17
18
18
181817171617161616161616141414141414141414141414141313131313131313131313131212111111111111101010101010101010101099999999999999988888888888888888888888877,4000000000000010
   Retained Earnings 
-1,130
5,600
6,700
11,100
19,800
21,100
21,100
24,100
26,600
24,800
23,700
23,700
22,400
18,522
16,870
16,984
17,249
16,846
16,166
16,479
17,465
15,764
14,314
13,814
11,011
10,064
9,009
9,143
11,685
11,685
9,991
9,909
11,878
11,724
9,933
12,932
15,095
13,641
11,022
12,101
13,346
11,418
7,899
9,227
10,888
9,319
6,440
7,319
5,354
3,155
-1,470
-269
1,512
450
-1,804
-858
-1,989
-3,002
-3,976
-2,866
-4,699
-5,387
-7,316
-6,242
-5,790
-5,500
-7,219
-5,983
-5,385
-6,189
-9,327
-12,543
-13,219
-14,599
-16,165
-15,563
-16,819
-18,155
-19,282
-19,115
-19,687
24,952
22,646
21,869
22,144
22,187
8,986
7,929
4,533
3,520
2,282
1,854
-1,506
-2,315
-2,245
-2,653
-3,631
-2,574
-3,969
-7,947
2,642
10,490
13,231
14,198
11,753
12,303
8,863
3,722
-5,029
-5,0293,7228,86312,30311,75314,19813,23110,4902,642-7,947-3,969-2,574-3,631-2,653-2,245-2,315-1,5061,8542,2823,5204,5337,9298,98622,18722,14421,86922,64624,952-19,687-19,115-19,282-18,155-16,819-15,563-16,165-14,599-13,219-12,543-9,327-6,189-5,385-5,983-7,219-5,500-5,790-6,242-7,316-5,387-4,699-2,866-3,976-3,002-1,989-858-1,8044501,512-269-1,4703,1555,3547,3196,4409,31910,8889,2277,89911,41813,34612,10111,02213,64115,09512,9329,93311,72411,8789,9099,99111,68511,6859,1439,00910,06411,01113,81414,31415,76417,46516,47916,16616,84617,24916,98416,87018,52222,40023,70023,70024,80026,60024,10021,10021,10019,80011,1006,7005,600-1,130
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,112
41,237
41,552
41,640
41,715
41,760
42,867
43,101
43,141
43,235
43,607
44,618
48,560
53,811
54,664
54,698
55,256
56,329
56,377
56,378
56,378
56,378
56,378
56,447
56,567
57,347
58,034
58,065
58,606
58,805
59,471
59,667
59,847
60,027
60,215
60,413
60,611
60,894
61,674
102,735
99,265
0
0
105,634
106,162
108,131
0
111,482
113,789
0
0
00113,789111,4820108,131106,162105,6340099,265102,73561,67460,89460,61160,41360,21560,02759,84759,66759,47158,80558,60658,06558,03457,34756,56756,44756,37856,37856,37856,37856,37756,32955,25654,69854,66453,81148,56044,61843,60743,23543,14143,10142,86741,76041,71541,64041,55241,23741,1120000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000-54,138-51,015-49,55700-47,490-47,490-47,490-47,490-47,490-47,490-47,490-47,490-47,490-47,490-47,490-47,025-47,025-47,025-47,025-42,544-32,600-30,742-30,742-30,742-30,742-30,742-30,742-30,742-30,742-30,742-30,742-30,742-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,637-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,188-25,158-25,044-25,044-25,0440000000000000
   Other Stockholders Equity 
6,660
6,000
6,000
12,200
22,000
22,100
23,700
22,300
18,200
12,600
6,100
31,500
-3,300
4,131
4,149
4,277
4,234
4,248
4,248
4,248
4,540
4,540
8,216
8,216
8,427
8,427
8,444
8,444
10,539
10,539
10,553
10,553
11,833
11,873
11,873
11,873
13,383
13,469
14,966
14,966
16,200
16,200
16,200
16,363
17,302
17,310
17,314
17,359
17,281
12,411
16,348
16,537
15,693
18,393
18,604
18,764
18,828
19,009
19,507
19,149
19,523
19,669
19,807
19,919
21,090
21,386
21,484
21,598
22,034
23,109
27,120
27,335
28,263
28,380
29,022
30,188
30,343
30,451
30,557
30,661
30,770
31,102
29,241
20,137
16,402
16,484
17,189
17,514
17,811
18,123
18,412
18,687
18,975
19,227
19,504
18,299
14,184
55,245
51,775
56,317
56,145
56,077
55,147
53,993
51,105
47,529
49,789
54,132
54,694
54,69454,13249,78947,52951,10553,99355,14756,07756,14556,31751,77555,24514,18418,29919,50419,22718,97518,68718,41218,12317,81117,51417,18916,48416,40220,13729,24131,10230,77030,66130,55730,45130,34330,18829,02228,38028,26327,33527,12023,10922,03421,59821,48421,38621,09019,91919,80719,66919,52319,14919,50719,00918,82818,76418,60418,39315,69316,53716,34812,41117,28117,35917,31417,31017,30216,36316,20016,20016,20014,96614,96613,46913,38311,87311,87311,87311,83310,55310,55310,53910,5398,4448,4448,4278,4278,2168,2164,5404,5404,2484,2484,2484,2344,2774,1494,131-3,30031,5006,10012,60018,20022,30023,70022,10022,00012,2006,0006,0006,660



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue44,384
Cost of Revenue-28,145
Gross Profit16,23916,239
 
Operating Income (+$)
Gross Profit16,239
Operating Expense-37,852
Operating Income-21,613-21,613
 
Operating Expense (+$)
Research Development1,418
Selling General Administrative34,502
Selling And Marketing Expenses1,932
Operating Expense37,85237,852
 
Net Interest Income (+$)
Interest Income69
Interest Expense-1,275
Other Finance Cost-365
Net Interest Income-841
 
Pretax Income (+$)
Operating Income-21,613
Net Interest Income-841
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-22,800-20,426
EBIT - interestExpense = -22,888
-22,800
-15,507
Interest Expense1,275
Earnings Before Interest and Taxes (EBIT)-21,613-21,525
Earnings Before Interest and Taxes (EBITDA)-14,915
 
After tax Income (+$)
Income Before Tax-22,800
Tax Provision--5,849
Net Income From Continuing Ops-10,475-16,951
Net Income-16,782
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses65,997
Total Other Income/Expenses Net-1,187841
 

Technical Analysis of ProPhase Labs Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ProPhase Labs Inc. The general trend of ProPhase Labs Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ProPhase Labs Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ProPhase Labs Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.005 < 7 < 7.48.

The bearish price targets are: 4.47 > 4.3734 > 4.335.

Tweet this
ProPhase Labs Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ProPhase Labs Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ProPhase Labs Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ProPhase Labs Inc. The current macd is -0.15940081.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ProPhase Labs Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ProPhase Labs Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ProPhase Labs Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ProPhase Labs Inc Daily Moving Average Convergence/Divergence (MACD) ChartProPhase Labs Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ProPhase Labs Inc. The current adx is 20.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ProPhase Labs Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
ProPhase Labs Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ProPhase Labs Inc. The current sar is 6.70506096.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ProPhase Labs Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ProPhase Labs Inc. The current rsi is 40.03. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
ProPhase Labs Inc Daily Relative Strength Index (RSI) ChartProPhase Labs Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ProPhase Labs Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ProPhase Labs Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ProPhase Labs Inc Daily Stochastic Oscillator ChartProPhase Labs Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ProPhase Labs Inc. The current cci is -131.38659184.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ProPhase Labs Inc Daily Commodity Channel Index (CCI) ChartProPhase Labs Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ProPhase Labs Inc. The current cmo is -28.2106674.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ProPhase Labs Inc Daily Chande Momentum Oscillator (CMO) ChartProPhase Labs Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ProPhase Labs Inc. The current willr is -97.68339768.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ProPhase Labs Inc Daily Williams %R ChartProPhase Labs Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ProPhase Labs Inc.

ProPhase Labs Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ProPhase Labs Inc. The current atr is 0.50967301.

ProPhase Labs Inc Daily Average True Range (ATR) ChartProPhase Labs Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ProPhase Labs Inc. The current obv is -106,021.

ProPhase Labs Inc Daily On-Balance Volume (OBV) ChartProPhase Labs Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ProPhase Labs Inc. The current mfi is 19.81.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
ProPhase Labs Inc Daily Money Flow Index (MFI) ChartProPhase Labs Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ProPhase Labs Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

ProPhase Labs Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ProPhase Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.029
Ma 20Greater thanMa 506.125
Ma 50Greater thanMa 1005.507
Ma 100Greater thanMa 2005.186
OpenGreater thanClose5.060
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ProPhase Labs Inc with someone you think should read this too:
  • Are you bullish or bearish on ProPhase Labs Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ProPhase Labs Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ProPhase Labs Inc

I send you an email if I find something interesting about ProPhase Labs Inc.


Comments

How you think about this?

Leave a comment

Stay informed about ProPhase Labs Inc.

Receive notifications about ProPhase Labs Inc in your mailbox!